Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29.1M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
65.8K
-
Shares change
-
+32K
-
Total reported value, excl. options
-
$8.23M
-
Value change
-
+$4.01M
-
Number of buys
-
2
-
Price
-
$125.91
Significant Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q4 2023
2 filings reported holding KRYS - Krystal Biotech, Inc. - COMMON STOCK as of Q4 2023.
Krystal Biotech, Inc. - COMMON STOCK (KRYS) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.8K shares
of 29.1M outstanding shares and own 0.23% of the company stock.
Largest 10 shareholders include Avoro Capital Advisors LLC (2.57M shares), VANGUARD GROUP INC (2.44M shares), FMR LLC (2.39M shares), BlackRock Inc. (1.81M shares), Redmile Group, LLC (1.73M shares), STATE STREET CORP (1.24M shares), Frazier Life Sciences Management, L.P. (988K shares), JENNISON ASSOCIATES LLC (724K shares), LORD, ABBETT & CO. LLC (618K shares), and DIMENSIONAL FUND ADVISORS LP (551K shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.